CAT No: CP25711
CAS No:288617-71-0
Synonyms/Alias:288617-71-0;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpent-4-enoic acid;Fmoc-alpha-allyl-L-alanine;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpent-4-enoic acid;4-Pentenoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-, (2S)-;Fmoc-(S)-2-(2-propenyl)Ala-OH;Fmoc-(Me)Gly(Allyl)-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylpent-4-enoic acid;(S)-N-Fmoc-2-(2'-propylenyl)alanine;Fmoc-alpha-allyl-L-Ala;FMOC-ALPHA-METHYL-L-ALLYLGLYCINE;MFCD02682444;(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-methylpent-4-enoic acid;SCHEMBL15005772;DTXSID40673974;(S)-N-(9-Fluorenylmethylcarbamate)-2-(2'-propylenyl)alanine;AKOS005762857;AKOS015948759;CS-W007052;HY-W007052;AC-27568;DS-16880;F12103;Fmoc-|A inverted exclamation mark-allyl-L-Ala;Fmoc-alpha-methyl-L-Allylglycine (Fmoc-L-aMeGly(Allyl)-OH);(2S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpent-4-enoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpent-4-enoicacid;
Chemical Name:(S)-2-(9-Fluorenylmethyloxycarbonyl)amino-2-methylpent-4-enoic acid (contains 20 to 50% MTBE)
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More